# FDA Inspection 1026556 - Cytovance Biologics Inc. - July 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/cytovance-biologics-inc/23b9870b-a1d7-4890-bb6f-c476414d80b4
Source feed: FDA_Inspections

> FDA Inspection 1026556 for Cytovance Biologics Inc. on July 20, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026556
- Company Name: Cytovance Biologics Inc.
- Inspection Date: 2017-07-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1089182 - 2019-05-09](https://www.keypedia.com/records/fda_inspections/cytovance-biologics-inc/d6179c1f-7a2a-4cce-9010-40bb23f19661)

Company: https://www.keypedia.com/companies/cytovance-biologics-inc/a03c370a-5e60-4617-95b1-521a1d305ac2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c